MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2024 All rights reserved. Tickeron Inc.

CYCN Cyclerion Therapeutics Forecast, Technical & Fundamental Analysis

a developer of pharmaceutical products for serious and orphan diseases

Industry Biotechnology
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
Ad is loading...
A.I. Advisor
published Earnings

CYCN is expected to report earnings to rise 75.00% to -28 cents per share on August 08

Cyclerion Therapeutics CYCN Stock Earnings Reports
Q2'23
Est.
$-0.28
Q1'23
Beat
by $0.14
Q4'22
Beat
by $0.12
Q3'22
Beat
by $5.96
Q2'22
Missed
by $0.01
The last earnings report on May 11 showed earnings per share of -15 cents, beating the estimate of -30 cents. With 15.28K shares outstanding, the current market capitalization sits at 4.45M.
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical products for serious and orphan diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
245 First Street
Phone
+1 857 327-8778
Employees
1
Web
https://www.cyclerion.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME27.370.91
+3.44%
GameStop Corp
AAPL228.223.10
+1.38%
Apple
SPY593.35-3.84
-0.64%
SPDR® S&P 500® ETF Trust
BTC.X87250.430000-3333.734400
-3.68%
Bitcoin cryptocurrency
TSLA311.18-19.06
-5.77%
Tesla

CYCN and Stocks

Correlation & Price change

A.I.dvisor tells us that CYCN and FRES have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CYCN and FRES's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYCN
1D Price
Change %
CYCN100%
-1.67%
FRES - CYCN
31%
Poorly correlated
+0.99%
ENTO - CYCN
25%
Poorly correlated
-17.24%
CGEN - CYCN
23%
Poorly correlated
-6.29%
KZIA - CYCN
23%
Poorly correlated
-7.54%
ZEOX - CYCN
21%
Poorly correlated
+1.44%
More